Development and characterization of nano-emulsions and nano-emulgels for transdermal delivery of statins

References

• Benito-Vicente A, Siddiqi H, Uribe KB, et al. (Asp47Asn) and p.(Thr62Met): non deleterious LDL receptor missense variants functionally characterized in vitro. Sci Rep. 2018;8:(1):1–6.
   PubMed Web of Science ®Google Scholar
• Bianconi V, Banach M, Pirro M. Why patients with familial hypercholesterolemia are at high cardiovascular risk? Beyond LDL-C levels. Trends Cardiovasc Med. 2020. DOI:10.1016/j.tcm.2020.03.004.
   PubMed Web of Science ®Google Scholar
• Mandraffino G, Scicali R, Rodríguez-Carrio J, et al. Arterial stiffness improvement after adding on PCSK9 inhibitors or ezetimibe to high-intensity statins in patients with familial hypercholesterolemia: a two-lipid center real-world experience. J Clin Lipidol. 2020;14(2):231–240.
   PubMed Web of Science ®Google Scholar
• Migliara G, Baccolini V, Rosso A, et al. Familial hypercholesterolemia: a systematic review of guidelines on genetic testing and patient management, Front. Public Health. 2017;5:252.
   Web of Science ®Google Scholar
• Akioyamen LE, Genest J, Chu A, et al. Risk factors for cardiovascular disease in heterozygous familial hypercholesterolemia: A systematic review and meta-analysis. J Clin Lipidol. 2019;13(1):15–30.
   PubMed Web of Science ®Google Scholar
• Jackson CL, Keeton JZ, Eason SJ, et al. Identifying familial hypercholesterolemia using a blood donor screening program with more than 1 million volunteer donors. JAMA Cardiol. 2019;4(7):685–689.
   PubMed Web of Science ®Google Scholar
• Pang J, Chan DC, Hu M, et al. Watts, comparative aspects of the care of familial hypercholesterolemia in the “ten countries study”. J Clin Lipidol. 2019;13(2):287–300.
   PubMed Web of Science ®Google Scholar
• Mszar R, Buscher S, Taylor HL, et al. Familial hypercholesterolemia and the founder effect among franco-americans: a brief history and call to action. CJC Open. 2020;2(3):161–167.
   PubMedGoogle Scholar
• Pirazzi C, Håkansson L, Gustafsson C, et al. High prevalence of genetic determined familial hypercholesterolemia in premature coronary artery disease. Appl Clin Genet. 2019;12:71–78.
   PubMed Web of Science ®Google Scholar
• Raal F, Bahassi EM, Stevens B, et al. Cascade screening for familial hypercholesterolemia in South Africa reveals a significant number of subjects with more than one fh mutation: the wits find-fh program. Atherosclerosis. 2019;287:e67.
   Web of Science ®Google Scholar
• Pina A, Helgadottir S, Mancina RM, et al. Virtual genetic diagnosis for familial hypercholesterolemia powered by machine learning. Eur J Prev Cardiol. 2020;27(15):2047487319898951.
   Web of Science ®Google Scholar
• Safarova MS, Kullo IJ My approach to the patient with familial hypercholesterolemia. In: Mayo Clin Proc. Elsevier; 2016. p. 770–786.
   Google Scholar
• Korani S, Bahrami S, Korani M, et al. Parenteral systems for statin delivery: a review. Lipids Health Dis. 2019;18(1):193.
   PubMed Web of Science ®Google Scholar
• Schierwagen R, Uschner FE, Magdaleno F, et al. Rationale for the use of statins in liver disease. Am J Physiol Gastrointest Liver Physiol. 2017;312(5):G407–G412.
   PubMed Web of Science ®Google Scholar
• Mancini GJ, Tashakkor AY, Baker S, et al. Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian working group consensus update. Can J Cardiol. 2013;29(12):1553–1568.
   PubMed Web of Science ®Google Scholar
• Koziolek M, Alcaro S, Augustijns P, et al. The mechanisms of pharmacokinetic food-drug interactions - a perspective from the UNGAP group. Eur J Pharm Sci Off J Eur Fed Pharm Sci. 2019;134:31–59.
   PubMed Web of Science ®Google Scholar
• Morrow DIJ, McCarron PA, Woolfson AD. et al. Innovative strategies for enhancing topical and transdermal drug delivery. Open Drug Deliv J. 2007; 1.
   Google Scholar
• Naik A, Kalia YN, Guy RH. Transdermal drug delivery: overcoming the skin’s barrier function. Pharm Sci Technol Today. 2000;3(9):318–326.
   PubMedGoogle Scholar
• Ng KW, Lau WM Skin deep: the basics of human skin structure and drug penetration. In: Dragicevic N,  Maibach HI, editors. Percutaneous penetration enhancers: chemical methods in penetration enhancement. Berlin/Heidelberg: Springer-Verlag; 2015. p. 3–11.
   Google Scholar
• Joshi B, Singh G, Rana AC, et al. Emulgel: a comprehensive review on the recent advances in topical drug delivery. Int Res J Pharm. 2011;2:66–70.
   Google Scholar
• Gaber M, Medhat W, Hany M, et al. Protein-lipid nanohybrids as emerging platforms for drug and gene delivery: challenges and outcomes. J Control Release. 2017;254:75–91.
   PubMed Web of Science ®Google Scholar
• Zhou X, Hao Y, Yuan L, et al. Nano-formulations for transdermal drug delivery: a review. Chin Chem Lett. 2018;29(12):1713–1724.
   Web of Science ®Google Scholar
• Zidan AS, Hosny KM, Ahmed OA, et al. Assessment of simvastatin niosomes for pediatric transdermal drug delivery. Drug Deliv. 2016;23(5):1536–1549.
   PubMed Web of Science ®Google Scholar
• Morsy MA, Abdel-Latif RG, Nair AB, et al. Preparation and evaluation of atorvastatin-loaded nanoemulgel on wound-healing efficacy. Pharmaceutics. 2019;11(11):609.
   PubMed Web of Science ®Google Scholar
• Wang L. Evaluation of Siberian Apricot (Prunussibirica L.) germplasm variability for biodiesel properties. J Am Oil Chem Soc. 2012;89:1743–1747.
   Web of Science ®Google Scholar
• Vermaak I, Kamatou GPP, Komane-Mofokeng B, et al. African seed oils of commercial importance—cosmetic applications. S Afr J Bot. 2011;77(4):920–933.
   Web of Science ®Google Scholar
• Wang Y, Fan Q, Song Y, et al. Effects of fatty acids and iontophoresis on the delivery of midodrine hydrochloride and the structure of human skin. Pharm Res. 2003;20(10):1612–1618.
   PubMed Web of Science ®Google Scholar
• Marais S, Du Preez JL, Du Plessis LH, et al. Determination of lovastatin, mevastatin, rosuvastatin and simvastatin with HPLC by means of gradient elution. Pharm. 2019;74:658–660.
   Google Scholar
• Maree S. A novel HPLC method developed and validated for the detection and quantification of atorvastatin, fluvastatin, pitavastatin and pravastatin during transdermal delivery studies. Pharm. 2020;75:163–165.
   Google Scholar
• Chime SA, Kenechukwu FC, Attama AA. Nanoemulsions—advances in formulation, characterization and applications in drug delivery. IntechOpen. 2014. DOI:10.5772/58673.
   Google Scholar
• Gaur S, Garg A, Yadav D, et al. Nanoemulsion gel as novel oil based colloidal nanocarrier for topical delivery of bifonazole. Indian Res J Pharm Sci. 2014;1:36–54.
   Google Scholar
• Nomaki H, Toyofuku T, Tsuchiya M, et al. Three-dimensional observation of foraminiferal cytoplasmic morphology and internal structures using uranium–osmium staining and micro-X-ray computed tomography. Mar Micropaleontol. 2015;121:32–40.
   Web of Science ®Google Scholar
• Gaumet M, Vargas A, Gurny R. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur J Pharm Biopharm. 2008;69(1):1–9.
   PubMed Web of Science ®Google Scholar
• Basera K, Kothiyal P, Gupta P. Nanoemulgel: a novel formulation approach for topical delivery of hydrophobic drugs. World J Pharm Sci. 2015;4:1871–1886.
   Google Scholar
• Abdalla KF, Kamoun EA, El Maghraby GM. Optimization of the entrapment efficiency and release of ambroxol hydrochloride alginate beads. J Appl Pharm Sci. 2015;5:13–19.
   Google Scholar
• Baert B, Vansteelandt S, De Spiegeleer B. Ion mobility spectrometry as a high-throughput technique for in vitro transdermal Franz diffusion cell experiments of ibuprofen. J Pharm Biomed Anal. 2011;55(3):472–478.
   PubMed Web of Science ®Google Scholar
• Pellett MA, Roberts MS, Hadgraft J. Supersaturated solutions evaluated with an in vitro stratum corneum tape stripping technique. Int J Pharm. 1997;151(1):91–98.
   Web of Science ®Google Scholar
• Sheskin DJ. Handbook of parametric and nonparametric statistical procedures. Boca Raton, Florida: Chapman & Hall/CRC. 2000.
   Google Scholar
• Krzywinski M, Altman N. Visualizing samples with box plots. Nat Methods. 2014;11:119–120.
   PubMed Web of Science ®Google Scholar
• Concato J, Hartigan JA. P values: from suggestion to superstition. J Investig Med. 2016;64:1166–1171.
   PubMed Web of Science ®Google Scholar
• Nalini T, Kumari S, Basha K. Novel nanosystems for herbal drug delivery. World J Pharm Sci. 2017;6:1447–1463.
   Google Scholar
• Honary S, Zahir F. Effect of zeta potential on the properties of nano-drug delivery systems-a review (part 1). Trop J Pharm Res. 2013;12:255–264.
   Web of Science ®Google Scholar
• Honary S, Zahir F. Effect of zeta potential on the properties of nano-drug delivery systems-a review (part 2). Trop J Pharm Res. 2013;12:265–273.
   Web of Science ®Google Scholar
• Wissing SA, Kayser O, Müller RH. Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev. 2004;56(9):1257–1272.
   PubMed Web of Science ®Google Scholar
• Ribeiro RCA, Barreto SMAG, Ostrosky EA, et al. Production and characterization of cosmetic nanoemulsions containing Opuntiaficus-indica (L.) mill extract as moisturizing agent. Molecules. 2015;20(2):2492–2509.
   PubMed Web of Science ®Google Scholar
• Drais HK, Hussein AA. Formulation characterization and evaluation of meloxicam nanoemulgel to be used topically. Iraq J Pharm Sci. 2017;26:9–16.
   Google Scholar
• Eid AM, El-Enshasy HA, Aziz R, et al. Preparation, characterization and anti-inflammatory activity of Swieteniamacrophyllananoemulgel. J Nanomed Nanotechnol. 2015;5:1.
   Google Scholar
• Chellapa P, Mohamed AT, Keleb EI, et al. Nanoemulsion and nanoemulgel as a topical formulation. IOSR J Pharm. 2015;5:43–47.
   Google Scholar
• Loureiro A, Nogueira E, Azoia NG, et al. Size controlled protein nanoemulsions for active targeting of folate receptor positive cells. Colloids Surf B Biointerfaces. 2015;135:90–98.
   PubMed Web of Science ®Google Scholar
• Divakaran D. Preparation and characterization of nanoemulsions encapsulating polyphenol extracts [PhD Thesis]. NDRI; 2012.
   Google Scholar
• Kurakula M, Srinivas C, Kasturi N, et al. Formulation and evaluation of prednisolone proliposomal gel for effective topical pharmacotherapy. Int J Pharm Sci Drug Res. 2012;4:35–43.
   Google Scholar
• Andrés A, Rosés M, Ràfols C, et al. Setup and validation of shake-flask procedures for the determination of partition coefficients (log D) from low drug amounts. Eur J Pharm Sci. 2015;76:181–191.
   PubMed Web of Science ®Google Scholar
• N’Da DD. Prodrug strategies for enhancing the percutaneous absorption of drugs. Molecules. 2014;19(12):20780–20807.
   PubMed Web of Science ®Google Scholar
• Vraka C, Nics L, Wagner KH, et al. LogP, a yesterday’s value? Nucl Med Biol. 2017;50:1–10.
   PubMed Web of Science ®Google Scholar
• Arora R, Aggarwal G, Harikumar SL. Nanoemulsion based hydrogel for enhanced transdermal delivery of ketoprofen. Adv Pharm. 2014;e468456. DOI:10.1155/2014/468456.
   Google Scholar
• Mahesh B, Vasanth KP, Gowda DV, et al. Enhanced permeability of cyclosporine from a transdermally applied nanoemulgel. Pharm Sin. 2015;6:69–79.
   Google Scholar
• Manikandan S. Measures of central tendency: the mean. J Pharmacol Pharmacother. 2011;2(2):140.
   PubMedGoogle Scholar
• Begur M, Pai VK, Gowda DV, et al. Enhanced permeability of cyclosporine from a transdermally applied nanoemulgel. Der Pharmacia Sinica. 2015;6(2):69-79.
   Google Scholar
• Jankowski A, Dyja R, Sarecka-Hujar B. Dermal and transdermal delivery of active substances from semisolid bases. Indian J Pharm Sci. 2017;79(4):488–500.
   Web of Science ®Google Scholar
• Liu C, Quan P, Fang L. Effect of drug physicochemical properties on drug release and their relationship with drug skin permeation behaviors in hydroxyl pressure sensitive adhesive. Eur J Pharm Sci. 2016;93:437–446.
   PubMed Web of Science ®Google Scholar
• Serajuddin AT. Salt formation to improve drug solubility. Adv Drug Deliv Rev. 2007;59(7):603–616.
   PubMed Web of Science ®Google Scholar
• Dev A, Chodankar R, Shelke O. Emulgels: a novel topical drug delivery system. Pharm Biol Eval. 2015;2:64–75.
   Google Scholar
• Aliyar H, Schalau G. Recent developments in silicones for topical and transdermal drug delivery. Ther Deliv. 2015;6(7):827–839.
   PubMed Web of Science ®Google Scholar
• DeGorter MK, Tirona RG, Schwarz UI, et al. Clinical and pharmacogenetic predictors of circulating atorvastatin and rosuvastatin concentrations in routine clinical care. Circ Cardiovasc Genet. 2013;6(4):400–408.
   PubMed Web of Science ®Google Scholar
• Siekmeier R, Lattke P, Mix C, et al. Dose dependency of fluvastatin pharmacokinetics in serum determined by reversed phase HPLC. J Cardiovasc Pharmacol Ther. 2001;6(2):137–145.
   PubMedGoogle Scholar
• Masana L. Therapeutic good administration, Australian public assessment report for Pitavastatin. 2013;128.
   Google Scholar
• Clarke EGC, Moffat AC, Osselton MD, et al. Clarke’s analysis of drugs and poisons: in pharmaceuticals, body fluids and postmortem material. 4rd. Vol. 1947. London; Chicago: Pharmaceutical Press; 2011.
   Google Scholar
• Björkhem-Bergman L, Lindh JD, Bergman P. What is a relevant statin concentration in cell experiments claiming pleiotropic effects? Br J Clin Pharmacol. 2011;72(1):164–165.
   PubMed Web of Science ®Google Scholar
• Nastiti CM, Ponto T, Abd E, et al. Topical nano and microemulsions for skin delivery. Pharmaceutics. 2017;9(4):37.
   PubMed Web of Science ®Google Scholar
• Rai VK, Mishra N, Yadav KS, et al. Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery: formulation development, stability issues, basic considerations and applications. J Control Release. 2018;270:203–225.
   PubMed Web of Science ®Google Scholar
• Dawson B, Trapp RG. Basic and clinical biostatistics. 4th ed. New York: McGraw-Hill; 2004.
   Google Scholar
• Förster M, Bolzinger MA, Fessi H, et al. Topical delivery of cosmetics and drugs.Molecular aspects of percutaneous absorption and delivery. Eur J Dermatol. 2009;19(4):309–323.
   PubMed Web of Science ®Google Scholar
• Sugibayashi K. Skin permeation and disposition of therapeutic and cosmeceutical compounds. Japan: Springer; 2017.
   Google Scholar
• Zheng Y, Ouyang WQ, Wei YP, et al. Effects of Carbopol® 934 proportion on nanoemulsion gel for topical and transdermal drug delivery: a skin permeation study. Int J Nanomedicine. 2016;11:5971.
   PubMed Web of Science ®Google Scholar
• Haque T, Talukder MMU. Chemical enhancer: a simplistic way to modulate barrier function of the stratum corneum. Adv Pharm Bull. 2018;8(2):169.
   PubMed Web of Science ®Google Scholar